• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2023 Oct 6:S1201-9712(23)00738-5.
doi: 10.1016/j.ijid.2023.10.001. Online ahead of print. Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis

Marit L Schüz[SUP] 1 [/SUP], Leonie Dallmeyer[SUP] 1 [/SUP], Paraskevi C Fragkou[SUP] 2 [/SUP], Jimmy Omony[SUP] 3 [/SUP], Hanna Krumbein[SUP] 1 [/SUP], Ben L Hünerbein[SUP] 1 [/SUP], Chrysanthi Skevaki[SUP] 4 [/SUP]



Affiliations
Free article Abstract

Objectives: Since the beginning of the COVID-19 pandemic, efforts have been made to contain the spread of the virus. However, the epidemiological burden of other respiratory viruses during the pandemic is unclear. We aim to address the epidemiology of respiratory viruses on adults/adolescents since the beginning of the pandemic.
Methods: We systematically searched five databases and performed a meta-analysis to explore the pooled prevalence of respiratory viruses in different geographical regions, age groups and time periods and compared the prevalence between COVID-19-cases and non-COVID-19 patients.
Results: Enteroviruses/rhinoviruses were highly prevalent compared to other viruses. Different viruses were dominant in different regions. No significant differences in prevalence were found between different age groups, except for human metapneumovirus. There was an increase in prevalence of non-SARS-CoV-2 viruses in the second half of the pandemic (July 2021-December 2022). Comparison of COVID-19 and non-COVID patients showed a higher prevalence in the non-COVID group, significant for influenza, seasonal coronaviruses, and human parainfluenza viruses.
Conclusion: Our findings indicate that enteroviruses/rhinoviruses were less impacted by healthcare measures compared to other respiratory viruses. The relaxation of measures in the second half led to an increased pooled prevalence of infections. Several factors may explain the lower prevalence among individuals infected with COVID-19.

Keywords: epidemiology; pandemic; prevalence; respiratory virus.

 
Back
Top Bottom